Maurice L. Tainter

From Wikipedia, the free encyclopedia

Maurice L. Tainter (born 1899) was a pharmacologist and professor at Stanford University.[1] He helped pioneer the use of 2,4-dinitrophenol for weight loss, but the drug was later banned due to its safety profile.[2][3] In 1943, he left Stanford for a job at Winthrop Company.[1] In 1960, he began working for Sterling Drug.[4]

References[edit]

  1. ^ a b "Medical News". Journal of the American Medical Association. 122 (4): 243. 22 May 1943. doi:10.1001/jama.1943.02840210035014.
  2. ^ Swann, John P. (2010). "Reducing with dinitrophenol : self-medication, and the challenge of regulating a dangerous pharmaceutical before the US Food, Drug, and Cosmetic Act". Perspectives on Twentieth-century Pharmaceuticals. Peter Lang. p. 286. ISBN 978-3-03910-920-3.
  3. ^ Sousa, Daniela; Carmo, Helena; Roque Bravo, Rita; Carvalho, Félix; Bastos, Maria de Lourdes; Guedes de Pinho, Paula; Dias da Silva, Diana (April 2020). "Diet aid or aid to die: an update on 2,4-dinitrophenol (2,4-DNP) use as a weight-loss product". Archives of Toxicology. 94 (4): 1071–1083. doi:10.1007/s00204-020-02675-9.
  4. ^ "Maurice L. Tainter". BioScience. 16 (10): 687. 1 October 1966. doi:10.1093/bioscience/16.10.687.